Free Trial
LON:SCLP

Scancell (SCLP) Share Price, News & Analysis

Scancell logo
GBX 84 +2.00 (+2.44%)
As of 11:57 AM Eastern

About Scancell Stock (LON:SCLP)

Advanced

Key Stats

Today's Range
80.30
▼
84
50-Day Range
80
▼
101.65
52-Week Range
79
▼
295
Volume
25,570 shs
Average Volume
264,039 shs
Market Capitalization
£113.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Scancell (LSE:SCLP) is a clinical stage company leveraging two proprietary platforms, Immunobody® and Moditope®, to develop targeted off-the-shelf, patient-accessible active immunotherapies for a cancer-free future. The lead product iSCIB1+ is an Immunobody® DNA active immunotherapy that has demonstrated monotherapy activity in adjuvant melanoma. When combined with checkpoint therapies it showed additional clinical benefit over the checkpoints (CPI) alone in the ongoing Phase 2 SCOPE trial in advanced melanoma. The precise patient population that iSCIB1+ brings benefit to, in combination with CPIs, has been identified, enabling precision-biomarker led registrational development. The lead Moditope® peptide active immunotherapy, Modi-1, is being investigated in a Phase 2 study in a broad range of solid tumours and also has shown encouraging interim clinical data. Scancell’s wholly-owned subsidiary, Glymab Therapeutics Ltd., has been established with the intention to develop an exciting early-stage pipeline of high affinity GlyMab® antibodies targeting tumour specific glycans, two of which already have been licensed and are being developed by Genmab A/S.

Receive SCLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scancell and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SCLP Stock News Headlines

Issue of Equity, Director Dealing & Voting Rights
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.tc pixel
See More Headlines

SCLP Stock Analysis - Frequently Asked Questions

Scancell's stock was trading at GBX 101.20 at the start of the year. Since then, SCLP stock has decreased by 17.0% and is now trading at GBX 84.

Scancell Holdings plc (LON:SCLP) released its quarterly earnings data on Friday, October, 9th. The company reported GBX (17.30) EPS for the quarter. Scancell had a positive trailing twelve-month return on equity of 128.87% and a negative net margin of 116.98%.

Shares of Scancell reverse split before market open on Wednesday, October 21st 2026.The 1-10 reverse split was announced on Wednesday, October 21st 2026. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 21st 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of SCLP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Scancell investors own include Petropavlovsk (POG), Lloyds Banking Group (LLOY), Genel Energy (GENL), Gulf Keystone Petroleum (GKP), KAZ Minerals (KAZ), AstraZeneca (AZN) and EKF Diagnostics (EKF).

Company Calendar

Last Earnings
10/09/2026
Today
11/16/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
LON:SCLP
CIK
N/A
Fax
N/A
Employees
51
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (17.30)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£6.75 million
Net Margins
-116.98%
Pretax Margin
N/A
Return on Equity
128.87%
Return on Assets
-45.28%

Debt

Debt-to-Equity Ratio
-88.01
Current Ratio
0.28
Quick Ratio
13.01

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 10.69 per share
Price / Cash Flow
7.86
Book Value
GBX (0.39) per share
Price / Book
-215.50

Miscellaneous

Outstanding Shares
135,668,000
Free Float
N/A
Market Cap
£113.96 million
Optionable
Not Optionable
Beta
0.69
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (LON:SCLP) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners